Sep 16, 2020 / 06:00PM GMT
Jessica Chutter - Morgan Stanley - Chairman of Biotechnology Investment Banking
Good afternoon. This is Jessica Chutter from Morgan Stanley, and we're very pleased to be hosting the fireside chat for Intra-Cellular Therapies. And with us today, we have Sharon Mates, Chief Executive Officer; Mark Neumann, Chief Commercial Officer; and Andy Satlin, Chief Medical Officer.
Before we start, I have to read a webcast disclaimer. Please note that this webcast is for Morgan Stanley clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representatives.
Okay. Great. Well, with that behind us, Sharon, it's obviously been a very, very exciting time for Intra-Cellular with your launch of
Intra-Cellular Therapies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot